Biomarkers Market Report

Biomarkers Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Dec 26, 2019
  • PAGES：178
  • REPORT CODE：GMM412848
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Biomarkers market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.5% during the forecast period.

    This report presents the market size and development trends by detailing the Biomarkers market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Biomarkers market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Biomarkers industry and will help you to build a panoramic view of the industrial development.

    Biomarkers Market, By Type:

    • Biomarker of Exposure

    • Biomarker of Diseases

    Biomarkers Market, By Application:

    • Risk Assessment

    • Development of Molecular Diagnostic

    • Disease Diagnosis

    • Drug Discovery and Development

    • Drug Formulation

    • Forensic Application

    • Others (DNA Fingerprinting and Others)

    Some of the leading players are as follows:

    • Eisai

    • Siemens

    • Ge Healthcare

    • Epistem

    • Bio-Rad Laboratories

    • Aushon Biosystem

    • Thermo Fisher Scientific

    • Abbott Laboratories

    • Roche Diagnostics

    • Agilent Technologies

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Biomarkers Market: Technology Type Analysis

    • 4.1 Biomarkers Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Biomarkers Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Biomarker of Exposure

      • 4.3.2 Biomarker of Diseases

    5 Biomarkers Market: Product Analysis

    • 5.1 Biomarkers Product Market Share Analysis, 2018 & 2026

    • 5.2 Biomarkers Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Biomarkers Market: Application Analysis

    • 6.1 Biomarkers Application Market Share Analysis, 2018 & 2026

    • 6.2 Biomarkers Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Risk Assessment

      • 6.3.2 Development of Molecular Diagnostic

      • 6.3.3 Disease Diagnosis

      • 6.3.4 Drug Discovery and Development

      • 6.3.5 Drug Formulation

      • 6.3.6 Forensic Application

      • 6.3.7 Others (DNA Fingerprinting and Others)

    7 Biomarkers Market: Regional Analysis

    • 7.1 Biomarkers Regional Market Share Analysis, 2018 & 2026

    • 7.2 Biomarkers Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Eisai

      • 9.1.1 Eisai Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Siemens

      • 9.2.1 Siemens Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Ge Healthcare

      • 9.3.1 Ge Healthcare Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Epistem

      • 9.4.1 Epistem Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Bio-Rad Laboratories

      • 9.5.1 Bio-Rad Laboratories Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Aushon Biosystem

      • 9.6.1 Aushon Biosystem Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Thermo Fisher Scientific

      • 9.7.1 Thermo Fisher Scientific Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Abbott Laboratories

      • 9.8.1 Abbott Laboratories Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Roche Diagnostics

      • 9.9.1 Roche Diagnostics Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Agilent Technologies

      • 9.10.1 Agilent Technologies Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

     

    The List of Tables and Figures (Totals 112 Figures and 132 Tables)

    • Figure Biomarker of Exposure Biomarkers market, 2015 - 2026 (USD Million)

    • Figure Biomarker of Diseases Biomarkers market, 2015 - 2026 (USD Million)

    • Figure Risk Assessment market, 2015 - 2026 (USD Million)

    • Figure Development of Molecular Diagnostic market, 2015 - 2026 (USD Million)

    • Figure Disease Diagnosis market, 2015 - 2026 (USD Million)

    • Figure Drug Discovery and Development market, 2015 - 2026 (USD Million)

    • Figure Drug Formulation market, 2015 - 2026 (USD Million)

    • Figure Forensic Application market, 2015 - 2026 (USD Million)

    • Figure Others (DNA Fingerprinting and Others) market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Biomarkers market, by country, 2015 - 2026 (USD Million)

    • Table North America Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table North America Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table North America Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table Canada Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table Canada Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Europe Biomarkers market, by country, 2015 - 2026 (USD Million)

    • Table Europe Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table Europe Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table Europe Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table Germany Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table Germany Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table France Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table France Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table Italy Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table Italy Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table Spain Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table Spain Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Biomarkers market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table China Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table China Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table Japan Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table Japan Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table India Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table India Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Biomarkers market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table MEA Biomarkers market, by country, 2015 - 2026 (USD Million)

    • Table MEA Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table MEA Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table MEA Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Biomarkers market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Biomarkers market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Biomarkers market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Eisai Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Siemens Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Ge Healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Epistem Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bio-Rad Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Aushon Biosystem Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Thermo Fisher Scientific Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Roche Diagnostics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Agilent Technologies Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US